Non-Opioid Pain Management After Mohs Reconstruction: An Investigator-Initiated, Prospective, Randomized Clinical Trial of Suzetrigine vs Hydrocodone/Acetaminophen
试验速览
- 阶段
- 4 期
- 状态
- Enrolling By Invitation
- 入组人数
- 75
- 试验地点
- 1
研究概览
简要总结
To compare suzetrigine versus hydrocodone/acetaminophen for postoperative pain control following dermatologic surgery.
详细描述
This study is a randomized, controlled trial that is evaluating the safety and efficacy of suzetrigine as a postoperative pain medication compared to the standard of care Hydrocodone/Acetaminophen in patients undergoing Mohs micrographic surgery (MMS) who are at high-risk for postoperative pain and opioid use. The goal is to reduce opioid prescription use and give patients a non-opioid pain medication option for particularly painful surgeries. Patients will be randomized into one of two groups, one group will receive the interventional medication and the other the standard of care medication.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 89 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adults between the age of 18-89
- •individuals who have a cutaneous tumor treated by MMS
排除标准
- •individuals younger than 18 and older than 89
- •individuals taking medications that interact with the CYP3A (Cytochrome P450 3A) pathway
- •individuals with liver disease
